191 related articles for article (PubMed ID: 23657751)
41. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
[TBL] [Abstract][Full Text] [Related]
42. Management of occluded metallic stents in malignant hilar biliary stricture.
Fujii M; Kawamoto H; Tsutsumi K; Kato H; Hirao K; Kurihara N; Mizuno O; Ishida E; Ogawa T; Fukatsu H; Yamamoto K
Hepatogastroenterology; 2013 May; 60(123):447-51. PubMed ID: 23108079
[TBL] [Abstract][Full Text] [Related]
43. Modified Glasgow prognostic score can predict survival of muscle invasive bladder cancer patients after radiotherapy.
Kikuchi K; Nakamura R; Segawa T; Oikawa H; Ariga H
J Radiat Res; 2020 Jul; 61(4):616-621. PubMed ID: 32567660
[TBL] [Abstract][Full Text] [Related]
44. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.
Paik WH; Park YS; Hwang JH; Lee SH; Yoon CJ; Kang SG; Lee JK; Ryu JK; Kim YT; Yoon YB
Gastrointest Endosc; 2009 Jan; 69(1):55-62. PubMed ID: 18657806
[TBL] [Abstract][Full Text] [Related]
45. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.
Saito H; Noji T; Okamura K; Tsuchikawa T; Shichinohe T; Hirano S
Surgery; 2016 Mar; 159(3):842-51. PubMed ID: 26683498
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer.
Martin HL; Ohara K; Kiberu A; Van Hagen T; Davidson A; Khattak MA
Intern Med J; 2014 Jul; 44(7):676-82. PubMed ID: 24750233
[TBL] [Abstract][Full Text] [Related]
47. Prediction of Treatment Response and Survival with Chemotherapy for Metastatic Penile Cancer by the Modified Glasgow Prognostic Score.
Draeger DL; Groh S; Buchholz T; Woehl M; Nolting J; Hakenberg OW
Urol Int; 2023; 107(5):489-495. PubMed ID: 34610603
[TBL] [Abstract][Full Text] [Related]
48. Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer.
Jiang X; Hiki N; Nunobe S; Kumagai K; Kubota T; Aikou S; Sano T; Yamaguchi T
Br J Cancer; 2012 Jul; 107(2):275-9. PubMed ID: 22713657
[TBL] [Abstract][Full Text] [Related]
49. [Treatment of malignant biliary occlusion by means of transhepatic percutaneous biliary drainage with insertion of metal stents--results of an 8-year follow-up and analysis of the prognostic parameters].
Alfke H; Alfke B; Froelich JJ; Klose KJ; Wagner HJ
Rofo; 2003 Aug; 175(8):1125-9. PubMed ID: 12886483
[TBL] [Abstract][Full Text] [Related]
50. Comparative Study of Percutaneous Transhepatic Biliary Stent Placement with or without Iodine-125 Seeds for Treating Patients with Malignant Biliary Obstruction.
Hasimu A; Gu JP; Ji WZ; Zhang HX; Zhu DW; Ren WX
J Vasc Interv Radiol; 2017 Apr; 28(4):583-593. PubMed ID: 28162906
[TBL] [Abstract][Full Text] [Related]
51. Combined percutaneous-endoscopic stenting of malignant biliary obstruction: results from 106 consecutive procedures and identification of factors associated with adverse outcome.
Neal CP; Thomasset SC; Bools D; Sutton CD; Garcea G; Mann CD; Rees Y; Newland C; Robinson RJ; Dennison AR; Berry DP
Surg Endosc; 2010 Feb; 24(2):423-31. PubMed ID: 19565296
[TBL] [Abstract][Full Text] [Related]
52. Comparison of outcomes among secondary covered metallic, uncovered metallic, and plastic biliary stents in treating occluded primary metallic stents in malignant distal biliary obstruction.
Cho JH; Jeon TJ; Park JY; Kim HM; Kim YJ; Park SW; Chung JB; Song SY; Bang S
Surg Endosc; 2011 Feb; 25(2):475-82. PubMed ID: 20602138
[TBL] [Abstract][Full Text] [Related]
53. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
[TBL] [Abstract][Full Text] [Related]
54. Newly designed plastic stent for endoscopic placement above the sphincter of Oddi in patients with malignant hilar biliary obstruction.
Ishiwatari H; Hayashi T; Ono M; Sato T; Kato J
Dig Endosc; 2013 May; 25 Suppl 2():94-9. PubMed ID: 23617658
[TBL] [Abstract][Full Text] [Related]
55. Clinical outcome of simultaneous self-expandable metal stents for palliation of malignant biliary and duodenal obstruction.
Kaw M; Singh S; Gagneja H
Surg Endosc; 2003 Mar; 17(3):457-61. PubMed ID: 12404053
[TBL] [Abstract][Full Text] [Related]
56. Impact of anticancer treatment on recurrent obstruction in covered metallic stents for malignant biliary obstruction.
Nakai Y; Isayama H; Mukai T; Itoi T; Maetani I; Kawakami H; Yasuda I; Maguchi H; Ryozawa S; Hanada K; Hasebe O; Ito K; Kawamoto H; Mochizuki H; Igarashi Y; Irisawa A; Sasaki T; Togawa O; Hara T; Kamada H; Toda N; Hamada T; Kogure H
J Gastroenterol; 2013 Nov; 48(11):1293-9. PubMed ID: 23354624
[TBL] [Abstract][Full Text] [Related]
57. Endoscopic Biliary Stenting Versus Percutaneous Transhepatic Biliary Stenting in Advanced Malignant Biliary Obstruction: Cost-effectiveness Analysis.
Sun XR; Tang CW; Lu WM; Xu YQ; Feng WM; Bao Y; Zheng YY
Hepatogastroenterology; 2014 May; 61(131):563-6. PubMed ID: 26176036
[TBL] [Abstract][Full Text] [Related]
58. Prognostication in advanced cancer: a study examining an inflammation-based score.
Partridge M; Fallon M; Bray C; McMillan D; Brown D; Laird B
J Pain Symptom Manage; 2012 Aug; 44(2):161-7. PubMed ID: 22732417
[TBL] [Abstract][Full Text] [Related]
59. A Case Series: Outcomes of Endoscopic Biliary Self-Expandable Metal Stent for Malignant Biliary Obstruction with Surgically Altered Anatomy.
Yamauchi H; Kida M; Okuwaki K; Miyazawa S; Iwai T; Imaizumi H; Eiji M; Hasegawa R; Koizumi W
Dig Dis Sci; 2016 Aug; 61(8):2436-2441. PubMed ID: 27033545
[TBL] [Abstract][Full Text] [Related]
60. Predictors of Recurrent Biliary Obstruction Following Percutaneous Uncovered Metal Stent Insertion in Patients with Distal Malignant Biliary Obstruction: An Analysis Using a Competing Risk Model.
Zhang JX; Wang B; Liu S; Zu QQ; Shi HB
Cardiovasc Intervent Radiol; 2019 Feb; 42(2):276-282. PubMed ID: 30411153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
